Experts like Michael Grosberg and Aryeh Sand highlight these challenges, noting that the inclusion of PBMs and the lack of regulation make weight management medication less accessible
The Intricate Relationship Between Obesity, Type 2 Diabetes and Female Breast Cancer: A Retrospective Study Of 335 Women
Millions of people are now using GLP-1 medications and peptides such as Ozempic (semaglutide), Wegovy, Mounjaro (tirzepatide) and retatrutide to support weight management
The US Food and Drug Administration (FDA) classifies chains of 40 amino acids or fewer as peptides. Because of their small, flat structure, peptides are able to bind with a number of chemical receptors throughout the body that larger molecules and drugs cannot access
The medicines regulator has issued a new safety warning for GLP-1-based drugs, like Ozempic, which could potentially cause a rare but serious eye disorder
There is also a lot talk around other antioxidants like vitamin C and vitamin D helping these conditions